• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket

    11/20/23 8:19:26 AM ET
    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Building Products
    Consumer Discretionary
    Get the next $ALGS alert in real time by email

    Shares of Applied UV, Inc. (NASDAQ:AUVI) shares jumped in pre-market trading after the company reported third-quarter results.

    Applied UV posted a quarterly loss of 32 cents per share, versus a year-ago loss of $1.20 per share. The company’s quarterly sales came in at $11.45 million up from $5.88 million, according to data from Benzinga Pro.

    Applied UV reaffirmed its previous guidance of approximately $45 million in revenue for 2023.

    Applied UV shares rose 96.1% to $0.29 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Bruush Oral Care Inc. (NASDAQ:BRSH) shares rose 172.2% to $0.4601 in pre-market trading. Brüush received Nasdaq notification regarding minimum bid requirements.
    • Blue Star Foods Corp. (NASDAQ:BSFC) shares surged 82.2% to $0.2526 in pre-market trading after jumping 18% on Friday. Blue Star Foods recently signed a 2-year bid award purchase agreement with Sysco Corporation.
    • Yoshiharu Global Co. (NASDAQ:YOSH) shares rose 34.2% to $0.47 in pre-market trading. The company recently reported an increase in quarterly sales.
    • MediciNova, Inc. (NASDAQ:MNOV) rose 18% to $2.10 in pre-market trading. The company announced new data and results of a Phase 2 clinical trial of MN-166 (ibudilast) in glioblastoma presented at the 28th Annual Meeting of the Society for Neuro-Oncology.
    • Motus GI Holdings, Inc. (NASDAQ:MOTS) gained 17.8% to $4.36 in pre-market trading after declining around 5% on Friday. Motus GI recently announced the Pure-Vu EVS Gastro was successfully used in the first procedure since receiving FDA clearance.
    • High Tide Inc.. (NASDAQ:HITI) shares climbed 16% to $1.38 in pre-market trading after declining around 5% on Friday.
    • LogicMark, Inc. (NASDAQ:LGMK) shares rose 13.8% to $1.90 in pre-market trading. LogicMark recently posted GAAP loss of $1.10 per share for the third quarter.
    • Transportadora de Gas del Sur S.A. (NYSE:TGS) rose 12.2% to $11.76 in pre-market trading after gaining over 4% on Friday.
    • Kronos Bio, Inc.(NASDAQ:KRON) gained 11.7% to $1.24 in pre-market trading. Kronos recently posted downbeat quarterly results.

    Losers

    • Safe and Green Development Corporation (NASDAQ:SGD) dipped 19% to $3.41 in pre-market trading. Safe And Green Development shares jumped 39% on Friday after the company said it does not intend to conduct the offering of the shares of common stock contemplated by the Registration Statement.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) shares fell 19% to $0.6364 in pre-market trading after gaining more than 95% on Friday.
    • Mural Oncology plc (NASDAQ:MURA) fell 17.6% to $4.07 in pre-market after jumping 30% on Friday.
    • Safe & Green Holdings Corp. (NASDAQ:SGBX) shares fell 16.6% to $0.6508 in pre-market trading after gaining around 7% on Friday. Safe & Green Holdings recently posted a narrower-than-expected quarterly loss.
    • Tharimmune, Inc. (NASDAQ:THAR) shares fell 16.6% to $0.1750 in pre-market trading. Tharimmune shares climbed around 17% on Friday after the company announced a 1-for-25 reverse stock split.
    • MGO Global, Inc. (NASDAQ:MGOL) shares fell 15.5% to $0.4650 in pre-market trading after jumping over 10% on Friday. MGO Global recently posted a wider third-quarter loss.
    • Syntec Optics Holdings, Inc. (NASDAQ:OPTX) fell 14.8% to $7.63 in pre-market trading after jumping 74% on Friday.
    • Assure Holdings Corp. (NASDAQ:IONM) fell 14.6% to $0.2466 in pre-market trading after declining around 7% on Friday.
    • Aligos Therapeutics, Inc. (NASDAQ:ALGS) shares fell 14% to $0.59 in pre-market trading. Aligos Therapeutics filed prospectus related to resale from time to time of up to 168.7 million shares of common stock, by selling securityholders.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) shares fell 9.2% to $0.69 in pre-market trading after jumping 38% on Friday.


    Now Read This: Agilent Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $ALGS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGS
    $AUVI
    $BRSH
    $BSFC

    CompanyDatePrice TargetRatingAnalyst
    Transportadora de Gas del Sur SA TGS
    $TGS
    10/31/2025$39.00Buy
    BofA Securities
    Aligos Therapeutics Inc.
    $ALGS
    8/18/2025$50.00Buy
    H.C. Wainwright
    Mural Oncology plc
    $MURA
    3/25/2025Overweight → Equal-Weight
    Morgan Stanley
    Mural Oncology plc
    $MURA
    3/25/2025$18.00Strong Buy → Outperform
    Raymond James
    Transportadora de Gas del Sur SA TGS
    $TGS
    2/12/2025$35.00Buy
    Citigroup
    Kronos Bio Inc.
    $KRON
    11/14/2024$6.00 → $1.00Overweight → Neutral
    Piper Sandler
    Kronos Bio Inc.
    $KRON
    11/14/2024Buy → Hold
    TD Cowen
    Aligos Therapeutics Inc.
    $ALGS
    8/19/2024$75.00Buy
    H.C. Wainwright
    More analyst ratings

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    SEC Filings

    View All

    SEC Form DEF 14C filed by Blue Star Foods Corp.

    DEF 14C - Blue Star Foods Corp. (0001730773) (Filer)

    2/23/26 4:51:03 PM ET
    $BSFC

    SEC Form 8-K filed by Medicinova Inc

    8-K - MEDICINOVA INC (0001226616) (Filer)

    2/20/26 6:25:19 AM ET
    $MNOV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tharimmune Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Canton Strategic Holdings, Inc. (0001861657) (Filer)

    2/18/26 8:45:45 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Bishop Walter A.

    4 - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Issuer)

    2/23/26 11:55:46 AM ET
    $OPTX
    Electronic Components
    Technology

    SEC Form 4 filed by Director Manzone Albert

    4 - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Issuer)

    2/23/26 11:50:52 AM ET
    $OPTX
    Electronic Components
    Technology

    SEC Form 4 filed by Director Rosenthal Brent D

    4 - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Issuer)

    2/23/26 11:45:55 AM ET
    $OPTX
    Electronic Components
    Technology

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Transportadora de Gas del Sur with a new price target

    BofA Securities initiated coverage of Transportadora de Gas del Sur with a rating of Buy and set a new price target of $39.00

    10/31/25 8:51:56 AM ET
    $TGS
    Natural Gas Distribution
    Utilities

    H.C. Wainwright resumed coverage on Aligos Therapeutics with a new price target

    H.C. Wainwright resumed coverage of Aligos Therapeutics with a rating of Buy and set a new price target of $50.00

    8/18/25 8:55:27 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Mural Oncology downgraded by Morgan Stanley

    Morgan Stanley downgraded Mural Oncology from Overweight to Equal-Weight

    3/25/25 12:58:54 PM ET
    $MURA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Gravitas Capital Lp bought $500,000 worth of shares (337,838 units at $1.48), increasing direct ownership by 86% to 732,424 units (SEC Form 4)

    4 - Tharimmune, Inc. (0001861657) (Issuer)

    6/23/25 9:29:23 PM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Parikh Sanam bought $1,450 worth of shares (1,000 units at $1.45), increasing direct ownership by 130% to 1,770 units (SEC Form 4)

    4 - Tharimmune, Inc. (0001861657) (Issuer)

    6/23/25 7:34:56 PM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Appajosyula Sireesh bought $90,973 worth of shares (61,496 units at $1.48), increasing direct ownership by 1,824% to 64,868 units (SEC Form 4)

    4 - Tharimmune, Inc. (0001861657) (Issuer)

    6/23/25 7:31:11 PM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)

    SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced positive data from two presentations at the Conference on Retroviruses and Opportunistic Infections (CROI), being held February 22 – 25, 2026 in Denver, Colorado. The pevifoscorvir sodium presentation highlights the Phase 1 monotherapy study of pevifoscorvir sodium, a potent CAM-E under development for the treatment of chronic hepatitis B virus (HBV) infection. Additionally, the ALG-097558 presentation showcases data from particip

    2/23/26 8:00:00 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy

    New NASDAQ Ticker Symbol "CNTN" to Begin Trading February 18, 2026Company Positioned to Support Institutional Adoption of First Privacy-Enabled Public Blockchain Processing $9 Trillion in Monthly Transaction VolumeNEW YORK, Feb. 17, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) (the "Company") the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the launch of a corporate rebrand in alignment with its digital asset treasury strategy. Effective Wednesday, February 18, 2026, the Company will change its name to Canton Strategic Holdings, Inc. In connection with the name change, the commo

    2/17/26 7:10:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RenX Enterprises Prices $6.0 Million Private Placement with Fixed Conversion Price

    MIAMI, FL, Feb. 13, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corporation (NASDAQ: RENX ("RenX" or the "Company"), a technology-driven environmental processing and sustainable materials company, today announced that it has entered into a securities purchase agreement for a private investment in public equity ("PIPE") financing for gross proceeds to the Company of approximately $6.0 Million, before deducting placement agent fees and offering expenses. Pursuant to the terms of the securities purchase agreement, the Company will issue to investors Senior Convertible Notes ("Notes") in the aggregate principal amount of $6.0 million. The Notes will bear interest at a rate of 12% per annum, wil

    2/13/26 9:00:00 AM ET
    $RENX
    $SGD
    Real Estate
    Finance

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Leadership Updates

    Live Leadership Updates

    View All

    Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

    Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, wh

    2/6/26 8:15:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tharimmune Elects Jill Sommers and William Wiley to Board of Directors

    New Directors Strengthen Governance as Company Advances Canton Network Infrastructure Former CFTC Commissioner Jill Sommers Brings Decades of Regulatory and Public Policy Experience DRW Chief of Staff William Wiley, CFA, Adds Extensive Leadership Experience Across Capital Markets and Global Operations NEW YORK, Feb. 2, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Jill Sommers and William Wiley, CFA, to the Board, effective February 1, 20

    2/2/26 8:15:00 AM ET
    $THAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer

    SOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (("Aligos", NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the appointment of James Hassard, MBA as Executive Vice President, Chief Commercial Officer, effective immediately. Mr. Hassard will lead and build the Company's global commercial capabilities and serve as a member of Aligos' Senior Leadership Team. Mr. Hassard is a seasoned executive with extensive experience building commercial organizations across multiple therapeutic areas. "As we continue to progress the Phase 2 B-

    1/13/26 8:00:00 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

    SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

    12/3/24 3:35:39 PM ET
    $LGMK
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Blue Star Foods Corp.

    SC 13G/A - Blue Star Foods Corp. (0001730773) (Subject)

    11/14/24 7:34:10 PM ET
    $BSFC

    Amendment: SEC Form SC 13G/A filed by Aligos Therapeutics Inc.

    SC 13G/A - Aligos Therapeutics, Inc. (0001799448) (Subject)

    11/14/24 6:57:50 PM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALGS
    $AUVI
    $BRSH
    $BSFC
    Financials

    Live finance-specific insights

    View All

    High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA

    The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana Club Members Now Exceed 2.5 Million, Up 45% Year Over Year, Marking the Fastest Pace in Four Quarters ELITE Members in Canada Have Surpassed 151,000, Once Again Growing at the Fastest Rate Since Inception In Fiscal 2025, Same-Store Sales Were Up 4.1%. For the Fourth Fiscal Quarter, Same-Store Sales Rose 5.5% Year Over YearThe Company Opened 27 New Canna Cabana Locations Organically in Calendar 2025, Achieving the Higher End of Its Communicated Goal, and Remains the Largest Cannabis Retailer in Canada with 21

    1/29/26 4:01:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Safe & Green Holdings to Rebrand as Olenox Industries, Aligning Corporate Identity with Integrated Energy and Infrastructure Strategy

    CONROE, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- via IBN -- Safe & Green Holdings Corp. (NASDAQ:SGBX) ("Safe & Green" or the "Company") today announced that it has begun executing a comprehensive corporate rebranding initiative, including a planned name change to Olenox Industries Inc. and a corresponding update to its trading symbol, reflecting the company's transformation into a fully integrated energy and infrastructure solutions platform. The rebrand is designed to align the company's market identity with its operating strategy, following a year of significant operational and strategic restructuring. As part of the initiative, the company will consolidate its existing subsidiaries int

    1/7/26 9:30:00 AM ET
    $SGBX
    RETAIL: Building Materials
    Consumer Discretionary

    Olenox Receives DOT Number; Prepares To Mobilize Service Division Assets

    CONROE, Texas, Nov. 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- Safe & Green Holdings Corp. (NASDAQ:SGBX) ("Safe & Green" or the "Company"), said that its wholly owned subsidiary Olenox Corp. received its DOT number and is preparing to mobilize its service assets. Safe & Green will start servicing its own assets and is preparing to hire a sales team to market the rigs and other service equipment to third parties as well. Michael McLaren, CEO, Safe & Green Holdings Corp., said: "This is a big step for us to get our service assets mobile and rekindle our O&G [Oil and Gas] service division. Our O&G service division is a key part of our production strategy, being able to do our own work greatly r

    11/24/25 11:44:25 AM ET
    $SGBX
    RETAIL: Building Materials
    Consumer Discretionary